277 related articles for article (PubMed ID: 18330714)
1. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
[TBL] [Abstract][Full Text] [Related]
2. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
3. Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Ahmed N; West D; Choudhary MI; Naz H; Gaffney J
BMC Cell Biol; 2009 Apr; 10():30. PubMed ID: 19389252
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
6. R-(-)-beta-O-methylsynephrine, a natural product, inhibits VEGF-induced angiogenesis in vitro and in vivo.
Kim NH; Pham NB; Quinn RJ; Kwon HJ
Biochem Biophys Res Commun; 2010 Aug; 399(1):20-3. PubMed ID: 20643105
[TBL] [Abstract][Full Text] [Related]
7. KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis.
Yi EY; Park SY; Song HS; Son MJ; Yi KY; Yoo SE; Kim YJ
Exp Mol Med; 2006 Oct; 38(5):502-8. PubMed ID: 17079866
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic function of tocotrienol.
Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
[TBL] [Abstract][Full Text] [Related]
10. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
[TBL] [Abstract][Full Text] [Related]
11. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
12. Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro.
Matou S; Colliec-Jouault S; Galy-Fauroux I; Ratiskol J; Sinquin C; Guezennec J; Fischer AM; Helley D
Biochem Pharmacol; 2005 Mar; 69(5):751-9. PubMed ID: 15710353
[TBL] [Abstract][Full Text] [Related]
13. A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo.
Kim Y; Jung HJ; Kwon HJ
Biochem Biophys Res Commun; 2012 Jan; 417(1):330-4. PubMed ID: 22155252
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
15. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
16. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2.
Hagedorn M; Zilberberg L; Lozano RM; Cuevas P; Canron X; Redondo-Horcajo M; Gimenez-Gallego G; Bikfalvi A
FASEB J; 2001 Mar; 15(3):550-2. PubMed ID: 11259363
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
18. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
Mader JS; Smyth D; Marshall J; Hoskin DW
Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
[TBL] [Abstract][Full Text] [Related]
19. Cheiradone: a vascular endothelial cell growth factor receptor antagonist.
Hussain S; Slevin M; Mesaik MA; Choudhary MI; Elosta AH; Matou S; Ahmed N; West D; Gaffney J
BMC Cell Biol; 2008 Jan; 9():7. PubMed ID: 18230134
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic activity of heparin-like polysulfonated polymeric drugs in 3D human cell culture.
García-Fernández L; Halstenberg S; Unger RE; Aguilar MR; Kirkpatrick CJ; San Román J
Biomaterials; 2010 Nov; 31(31):7863-72. PubMed ID: 20674006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
